Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Brown fat activity without fat browning

March 25, 2020

U.S. complete response letter issued for empagliflozin for type 1 diabetes

March 23, 2020

Drink plenty of water: Sugar shortens lifespan via dehydration, not metabolic defects

March 23, 2020

New knockout mice models and gene replacement therapy for Barth syndrome

March 23, 2020

Lexicon announces early close-out of long-term outcome studies of sotagliflozin

March 20, 2020

Comprehensive look identifies insulin autoantigens

March 20, 2020

Northwestern University synthesizes new glucosylceramidase modulators

March 19, 2020

Organ microbiomes associated with diabetes risk

March 18, 2020

Galectin-7 as new therapeutic target for the prevention of preeclampsia

March 17, 2020

Tera Stone discovers xanthine oxidase inhibitors

March 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...